A Concise Panel of Biomarkers Identifies Neurocognitive Functioning Changes in HIV-Infected Individuals

Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection

(2013) Tricia H. Burdo et al.   AIDS

Co-Morbidities in Persons Infected with HIV: Increased Burden with Older Age and Negative Effects on Health-Related Quality of Life

(2013) Alan T. Rodriguez-Penney et al.   AIDS PATIENT CARE AND STDS

Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer

(2013) Jerel Fields et al.   JOURNAL OF NEUROVIROLOGY

Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China

(2013) Lin Yuan et al.   JOURNAL OF NEUROVIROLOGY

Neurologic Complications and Considerations in HIV-Infected Persons

(2013) Justin McArthur et al.   Current Infectious Disease Reports

Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression

(2012) R. Thiebaut et al.   CLINICAL INFECTIOUS DISEASES

Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection

(2012) Anupa Kamat et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Prospective Memory and Antiretroviral Medication Non-Adherence in HIV: An Analysis of Ongoing Task Delay Length Using the Memory for Intentions Screening Test

(2012) Amelia J. Poquette et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

(2011) Ronald J. Ellis et al.   AIDS

Plasma sCD14 Is a Biomarker Associated With Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection

(2011) Jennifer L Lyons et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

(2011) Lucette A. Cysique et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals

(2011) Scott L. Letendre et al.   JOURNAL OF NEUROVIROLOGY

HIV-related neurocognitive impairment – A review

(2011) Simon Rackstraw   Psychology Health & Medicine

Neurocognitive Impact of Antiretroviral Treatment: Thinking Long-Term

(2011) Megan E. McPhail et al.   Current HIV/AIDS Reports

Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients

(2010) W. A. NOCKHER et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome

(2010) H. Zhang et al.   HUMAN REPRODUCTION

Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy–treated subjects with human immunodeficiency virus type 1 infection

(2010) Bing Sun et al.   JOURNAL OF NEUROVIROLOGY

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

(2010) Robert K. Heaton et al.   JOURNAL OF NEUROVIROLOGY

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Biomarkers of immune dysfunction in HIV

(2010) Daniel E Nixon et al.   Current Opinion in HIV and AIDS

The macrophage: the intersection between HIV infection and atherosclerosis

(2009) Suzanne M. Crowe et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

(2009) L. A. Cysique et al.   NEUROLOGY